Pesquisar um ensaio clínico
Outras opções de pesquisa
16 Resultado(s)
Ensaio em fase de recrutamento = 
; Ensaio a decorrer = 
; Financiado por um membro do IRDiRC = 
; Membro de uma ERN = 
Ensaio (s) clínico (s) nacional (is)
ALEMANHA
Baden-Württemberg
TÜBINGEN
MYCUV-IIT02: Myfortic (Enteric-coated Mycophenolate Sodium) for the treatment of Non-infectious Intermediate Uveitis - a prospective, controlled, randomized multicenter trial (Phase III) - DE
Department für Augenheilkunde Tübingen
Universitäts-Augenklinik
AUSTRALIA
Victoria
ADDRESS: NOT PROVIDED - AU
EYEGUARD-A: A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis (Phase III) - AU
Institution: Information not provided - AU
AUSTRALIA
Victoria
ADDRESS: NOT PROVIDED - AU
EYEGUARD-C: A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment (Phase III) - AU
Institution: Information not provided - AU
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
A Safety Study of Intravitreal PP-001 in Patients With Chronic, Non-Infectious Uveitis Having Chronic Inflammation (Phase 1-2) - AT
Institution: Information not provided - AT
CANADA
Québec
ADDRESS: NOT PROVIDED - CA
EYEGUARD-C: A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment (Phase III) - CA
Institution: Information not provided - CA
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
A Phase I/II, Open-label, Multicentre, Dose Escalation Study Assessing Safety/Tolerability of pEYS606 When Administered by Electrotransfer (ET) in Ciliary Muscle of Patients With Non-infectious Posterior, Intermediate or Panuveitis -GB
Institution: Information not provided - US
FRANCA
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
VISUAL III: A multicenter open-label study of the long-term safety and efficacy of the human anti-TNF monoclonal antibody adalimumab in subjects with non-infectious intermediate-, posterior-, or pan-uveitis (phase III) - FR
Institution: Information not provided - FR
PORTUGAL
CENTRO
ADDRESS: NOT PROVIDED - PT
EYEGUARD-C: A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment (Phase III) - PT
Institution: Information not provided - PT
PORTUGAL
CENTRO
ADDRESS: NOT PROVIDED - PT
EYEGUARD-A: A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis (Phase III) - PT
Institution: Information not provided - PT
REINO UNIDO
Surrey
LONDON
A randomised, active-controlled, open-label, multiple-dose, proof-of-concept study of intravitreal LFG316 in patients with active non-infectious intermediate-, posterior-, or panuveitis requiring systemic immunosuppressive therapy
Novartis Pharmaceuticals
Medical Collaboration Centre
TUNISIA
TUNISIA
ADDRESS: NOT PROVIDED - TN
EYEGUARD-C: A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Subjects With Non-infectious Intermediate, Posterior, or Pan-uveitis Currently Controlled With Systemic Treatment (Phase III) - TN
Institution: Information not provided - TN
FRANCA
ILE-DE-FRANCE
PARIS
Evaluation of the Efficacy of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis: Randomized Double-blind Placebo-controlled Trial - FR
Hôpital Necker-Enfants Malades
Service de Génétique Moléculaire
BELGICA
VLAAMS BRABANT
LEUVEN
HLA A29 study: Abatacept in Patients With Birdshot HLA A29 Uveitis: A Phase II Prospective open Label Interventional Proof-of-Concept Study
UZ Leuven - Campus Gasthuisberg
Dienst oogziekten/Ophthalmology
Ensaio (s) clínico (s) multinacional (ais)
ESTADOS UNIDOS
Washington
ADDRESS: NOT PROVIDED - US
A Phase I/II, Open-label, Multicentre, Dose Escalation Study Assessing Safety/Tolerability of pEYS606 When Administered by Electrotransfer (ET) in Ciliary Muscle of Patients With Non-infectious Posterior, Intermediate or Panuveitis
Institution: Information not provided - US
REINO UNIDO
Greater London
LONDON
EYEGUARD-A: A Randomized, Double-masked, Placebo-controlled Study of the Safety and Efficacy of Gevokizumab in the Treatment of Active Non-infectious Intermediate, Posterior, or Pan- Uveitis (Phase III) (TERMINATED)
Moorfield's Eye Hospital
REINO UNIDO
Greater London
LONDON